A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial-Reference-Cited by-同舟云学术

A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial

Published:2015-04 Issue:4 Volume:100 Page:1335-1342
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:The Journal of Clinical Endocrinology & Metabolism

Author:

Langdahl Bente L.,Teglbjærg Christence Stubbe,Ho Pei-Ran,Chapurlat Roland,Czerwinski Edward,Kendler David L.,Reginster Jean-Yves,Kivitz Alan,Lewiecki E. Michael,Miller Paul D.,Bolognese Michael A.,McClung Michael R.,Bone Henry G.,Ljunggren Östen,Abrahamsen Bo,Gruntmanis Ugis,Yang Yu-Ching,Wagman Rachel B.,Mirza Faisal,Siddhanti Suresh,Orwoll Eric

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoporosis Management in Patients with Hip Fracture post Fall;International Journal of Men's Social and Community Health;2024-08-29

2. Comparison of Denosumab with Romosozumab in the Treatment of Male Osteoporosis: A Retrospective Cohort Study;2024-06-20

3. Osteoporosis Management in Patients with Hip Fracture post Fall;International Journal of Men's Social and Community Health;2024-04-22

4. Pharmacological treatment of osteoporosis and prevention of fractures: recommendations for clinical practice;Vnitřní lékařství;2024-04-10

5. Ginsenoside Rb2 exhibits therapeutic value for male osteoporosis in orchiectomy mice by suppressing osteoclastogenesis and modulating NF-κB/MAPK signaling pathways;Food & Function;2024